Association of post-stroke-initiated antidepressants with long-term outcomes in young adults with ischaemic stroke

References

• Hackett ML, Yapa C, Parag V, et al. Frequency of depression after stroke: a systematic review of observational studies. Stroke. 2005;36(6):1330–1340.
   PubMed Web of Science ®Google Scholar
• Ayerbe L, Ayis S, Wolfe CDA, et al. Natural history, predictors and outcomes of depression after stroke: systematic review and Meta-analysis. Br J Psychiatry. 2013;202(1):14–21.
   PubMed Web of Science ®Google Scholar
• Towfighi A, Ovbiagele B, El Husseini N, et al. Poststroke depression: a scientific statement for healthcare professionals from the American heart association/American stroke association. Stroke. 2017;48(2):e30–e43.
   PubMed Web of Science ®Google Scholar
• Ayerbe L, Ayis S, Crichton S. The long-term outcomes of depression up to 10 years after stroke; the South London stroke register. J Neurol Neurosurg Psychiatry. 2014;85:514–521.
   PubMed Web of Science ®Google Scholar
• Mitchell AJ, Sheth B, Gill J, et al. Prevalence and predictors of post-stroke mood disorders: a Meta-analysis and Meta-regression of depression, anxiety and adjustment disorder. Gen Hosp Psychiatry. 2017;47:48–60.
   PubMed Web of Science ®Google Scholar
• Jørgensen TSH, Wium-Andersen IK, Wium-Andersen MK, et al. Incidence of depression after stroke, and associated risk factors and mortality outcomes, in a large cohort of Danish patients. JAMA Psychiatry. 2016;73(10):1032–1040.
   PubMed Web of Science ®Google Scholar
• Waje-Andreassen U, Thomassen L, Jusufovic M, et al. Ischaemic stroke at a young age is a serious event - final results of a population-based long-term follow-up in Western Norway. Eur J Neurol. 2013;20(5):818–823.
   PubMed Web of Science ®Google Scholar
• Ayerbe L, Ayis S, Crichton SL, et al. Explanatory factors for the increased mortality of stroke patients with depression. Neurology. 2014;83(22):2007–2012.
   PubMed Web of Science ®Google Scholar
• Chemerinski E, Robinson RG, Kosier JT. Improved recovery in activities of daily living associated with remission of poststroke depression. Stroke. 2001;32(1):113–117.
   PubMed Web of Science ®Google Scholar
• Schmid AA, Kroenke K, Hendrie HC, et al. Poststroke depression and treatment effects on functional outcomes. Neurology. 2011;76(11):1000–1005.
   PubMed Web of Science ®Google Scholar
• House A, Knapp P, Bamford J, et al. Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month. Stroke. 2001;32(3):696–701.
   PubMed Web of Science ®Google Scholar
• Van De Weg FB, Kuik DJ, Lankhorst GJ. Post-stroke depression and functional outcome: a cohort study investigating the influence of depression on functional recovery from stroke. Clin Rehabil. 1999;13(3):268–272.
   PubMed Web of Science ®Google Scholar
• Nannetti L, Paci M, Pasquini J, et al. Motor and functional recovery in patients with post-stroke depression motor and functional recovery in patients with post-stroke depression. Disabil Rehabil. 2005;27(4):170–175.
   PubMed Web of Science ®Google Scholar
• Naess H, Nyland H. Poststroke fatigue and depression are related to mortality in young adults: a cohort study. BMJ Open. 2013;3(3):e002404.
   PubMed Web of Science ®Google Scholar
• Mortensen JK, Larsson H, Johnsen SP, et al. Post stroke use of selective serotonin reuptake inhibitors and clinical outcome among patients with ischemic stroke: a nationwide propensity score-matched follow-up study. Stroke. 2013;44(2):420–426.
   PubMed Web of Science ®Google Scholar
• Juang HT, Chen PC, Chien KL. Using antidepressants and the risk of stroke recurrence: report from a national representative cohort study. BMC Neurol. 2015;15:86.
   PubMed Web of Science ®Google Scholar
• Broman J, Aarnio K, But A, et al. Initiation of antidepressants in young adults after ischemic stroke: a registry-based follow-up study. J Neurol. 2022;269(2):956–965.
   PubMed Web of Science ®Google Scholar
• Aho K, Harmsen P, Hatano S, et al. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ. 1980;58(1):113–130.
   PubMed Web of Science ®Google Scholar
• Putaala J, Metso AJ, Metso TM, et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke. 2009;40(4):1195–1203.
   PubMed Web of Science ®Google Scholar
• Tilastokeskus - Luokitukset - Sosioekonominen asema. Luokituksen kuvaus. 1989. [accessed 21 Oct 2018]. Available from: http://www.stat.fi/meta/luokitukset/sosioekon_asema/001-1989/kuvaus.html.
   Google Scholar
• Aarnio K, Siegerink B, Pirinen J, et al. Cardiovascular events after ischemic stroke in young adults: a prospective follow-up study. Neurology. 2016;86(20):1872–1879.
   PubMed Web of Science ®Google Scholar
• Austin PC. The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med. 2014;33(7):1242–1258.
   PubMed Web of Science ®Google Scholar
• Austin PC, Lee DS, Fine JP. Introduction to the analysis of survival data in the presence of competing risks. Circulation. 2016;133(6):601–609.
   PubMed Web of Science ®Google Scholar
• Pan A, Sun Q, Okereke OI, et al. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA. 2011;306(11):1241–1249.
   PubMed Web of Science ®Google Scholar
• Suttorp MM, Siegerink B, Jager KJ, et al. Graphical presentation of confounding in directed acyclic graphs. Nephrol Dial Transplant. 2015;30(9):1418–1423.
   PubMed Web of Science ®Google Scholar
• R Core Team. 2020. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
   Google Scholar
• Biffi A, Scotti L, Corrao G. Use of antidepressants and the risk of cardiovascular and cerebrovascular disease: a meta-analysis of observational studies. Eur J Clin Pharmacol. 2017;73(4):487–497.
   PubMed Web of Science ®Google Scholar
• Hankey GJ. Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised. Double-blind, placebo-controlled trial. 2020;19(8):651–660.
   Google Scholar
• Lundström E, Isaksson E, Näsman P, et al. Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2020;19(8):661–669.
   PubMed Web of Science ®Google Scholar
• Yuan K, Chen J, Xu P, et al. A nomogram for predicting stroke recurrence among young adults. Stroke. 2020;51(6):1865–1867.
   PubMed Web of Science ®Google Scholar
• Tolonen H, Salomaa V, Torppa J, et al. The validation of the Finnish hospital discharge register and causes of death register data on stroke diagnoses. Eur J Cardiovasc Prev Rehabil. 2007;14(3):380–385.
   PubMedGoogle Scholar
• Sund R. Quality of the Finnish hospital discharge register: a systematic review. Scand J Public Health. 2012;40(6):505–515.
   PubMed Web of Science ®Google Scholar
• Dahabreh IJ, Sheldrick RC, Paulus JK, et al. Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes. Eur Heart J. 2012;33(15):1893–1901.
   PubMed Web of Science ®Google Scholar
• Wen H, Weymann KB, Wood L, et al. Inflammatory signaling in Post-Stroke fatigue and depression. Eur Neurol. 2018;80(3–4):138–148.
   PubMed Web of Science ®Google Scholar